To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics

In India, the prevalence of overweight individuals is reported to be between 20-40% in various studies, with over 5-10% being obese. Obesity acts as a risk factor for asthma through various mechanisms and it also reduces the spirometric variables as well as total lung capacity and functional residua...

Full description

Bibliographic Details
Main Authors: Latha Sarma, Nandan Putti, Avinash Chaskar, Mohit Chilana KA, Asmath Qureshi
Format: Article
Language:English
Published: KIMS Foundation and Research Center 2015-09-01
Series:Journal of Medical and Scientific Research
Subjects:
Online Access:http://jmsronline.com/article.aspx?ID=The-influence-of-inhaled-bronchodilator-therapy-on-spirometric-test-obese-asthmatics
id doaj-9c4c1a219ee446cb9e4ceca62189454e
record_format Article
spelling doaj-9c4c1a219ee446cb9e4ceca62189454e2020-11-25T02:02:58ZengKIMS Foundation and Research CenterJournal of Medical and Scientific Research2321-13262394-112X2015-09-013416617110.17727/JMSR.2015/3-032To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmaticsLatha Sarma0Nandan Putti1Avinash Chaskar2Mohit Chilana KA3Asmath Qureshi4Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India.Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India.Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India.Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India.Department of Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad-500003, Telangana, India.In India, the prevalence of overweight individuals is reported to be between 20-40% in various studies, with over 5-10% being obese. Obesity acts as a risk factor for asthma through various mechanisms and it also reduces the spirometric variables as well as total lung capacity and functional residual capacity. Forced expiratory volume in one second (FEV1) was done on 100 patients in tertiary care hospital using RMS Helios 401 electronic spirometer, by Recorders and Medicare Systems Pvt. Ltd. All the statistical analysis was done using SPSS, Ver. 17.0, (IBM, Chicago, Illinois and student unpaired T-test and analysis of variance (ANOVA) test was used for estimating results. 59 were males and 41were females, of the 59 males, 29 were obese and 30 were non-obese and of the 41 females 20 were obese and 21 were non-obese. There was highly significant difference found in the spirometric variables in obese and non-obese asthmatics. There is significant amount of reversibility (% change) after inhalation of short acting beta-2 agonist in non-obese group as compared with obese group with mean percentage change in non-obese group being 16.20% and obese group 13.58%. p value 0.002(p<0.05). The amount of reversibility (mean % change) was found to be more for controlled asthmatic groups (16.88%) as compared with partly controlled asthmatics (14.84%) and uncontrolled asthmatic groups(12.78%) p value 0.001(p<0.05). To conclude, it can be said that age does not have any significant influence on the levels of asthma control in both obese and non-obese asthmatics. Obesity has a significant influence on various spirometric variables.http://jmsronline.com/article.aspx?ID=The-influence-of-inhaled-bronchodilator-therapy-on-spirometric-test-obese-asthmaticsasthmaobesenon-obesespirometry valuesreversibilitycross sectional study
collection DOAJ
language English
format Article
sources DOAJ
author Latha Sarma
Nandan Putti
Avinash Chaskar
Mohit Chilana KA
Asmath Qureshi
spellingShingle Latha Sarma
Nandan Putti
Avinash Chaskar
Mohit Chilana KA
Asmath Qureshi
To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
Journal of Medical and Scientific Research
asthma
obese
non-obese
spirometry values
reversibility
cross sectional study
author_facet Latha Sarma
Nandan Putti
Avinash Chaskar
Mohit Chilana KA
Asmath Qureshi
author_sort Latha Sarma
title To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
title_short To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
title_full To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
title_fullStr To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
title_full_unstemmed To evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
title_sort to evaluate the influence of inhaled bronchodilator therapy on spirometric test variables in obese and non-obese asthmatics
publisher KIMS Foundation and Research Center
series Journal of Medical and Scientific Research
issn 2321-1326
2394-112X
publishDate 2015-09-01
description In India, the prevalence of overweight individuals is reported to be between 20-40% in various studies, with over 5-10% being obese. Obesity acts as a risk factor for asthma through various mechanisms and it also reduces the spirometric variables as well as total lung capacity and functional residual capacity. Forced expiratory volume in one second (FEV1) was done on 100 patients in tertiary care hospital using RMS Helios 401 electronic spirometer, by Recorders and Medicare Systems Pvt. Ltd. All the statistical analysis was done using SPSS, Ver. 17.0, (IBM, Chicago, Illinois and student unpaired T-test and analysis of variance (ANOVA) test was used for estimating results. 59 were males and 41were females, of the 59 males, 29 were obese and 30 were non-obese and of the 41 females 20 were obese and 21 were non-obese. There was highly significant difference found in the spirometric variables in obese and non-obese asthmatics. There is significant amount of reversibility (% change) after inhalation of short acting beta-2 agonist in non-obese group as compared with obese group with mean percentage change in non-obese group being 16.20% and obese group 13.58%. p value 0.002(p<0.05). The amount of reversibility (mean % change) was found to be more for controlled asthmatic groups (16.88%) as compared with partly controlled asthmatics (14.84%) and uncontrolled asthmatic groups(12.78%) p value 0.001(p<0.05). To conclude, it can be said that age does not have any significant influence on the levels of asthma control in both obese and non-obese asthmatics. Obesity has a significant influence on various spirometric variables.
topic asthma
obese
non-obese
spirometry values
reversibility
cross sectional study
url http://jmsronline.com/article.aspx?ID=The-influence-of-inhaled-bronchodilator-therapy-on-spirometric-test-obese-asthmatics
work_keys_str_mv AT lathasarma toevaluatetheinfluenceofinhaledbronchodilatortherapyonspirometrictestvariablesinobeseandnonobeseasthmatics
AT nandanputti toevaluatetheinfluenceofinhaledbronchodilatortherapyonspirometrictestvariablesinobeseandnonobeseasthmatics
AT avinashchaskar toevaluatetheinfluenceofinhaledbronchodilatortherapyonspirometrictestvariablesinobeseandnonobeseasthmatics
AT mohitchilanaka toevaluatetheinfluenceofinhaledbronchodilatortherapyonspirometrictestvariablesinobeseandnonobeseasthmatics
AT asmathqureshi toevaluatetheinfluenceofinhaledbronchodilatortherapyonspirometrictestvariablesinobeseandnonobeseasthmatics
_version_ 1724950348510003200